For Immediate Release

Contact: Ed Wood President and CEO ArcScan, Inc. 303.526.9499 ewood@arcscan.com

ArcScan Announces Merger Agreement with Ultralink LLC

September 26 , 2007

ArcScan, Inc. today announced it has completed a merger agreement with Ultralink LLC of
St. Petersburg, Florida.

Ultralink introduced the Artemis™ VHF Digital Ultrasound Eye Arc-Scanner based on
technology developed and patented by Cornell University. The precision biometry afforded
by Ultralink's Artemis 2 device was lauded by users who have reported its high value for
planning LASIK surgery, the implantation of intraocular lenses and ocular diagnostics.

ArcScan plans to design and introduce a successor to the Artemis 2 device that will maintain
its high value to the ophthalmology profession and improve its ease of use.

ArcScan will continue to provide services to current users of Artemis 2 devices.

"ArcScan's investors are convinced that both the scientific and economic contributions from
re-introducing and upgrading the Artemis technology will be well received by customers and
new investors alive," said Ed Wood, ArcScan's President and CEO. "No other device can
display the eye's precise anatomical structure like the Artemis," he added.

George Wiseman (GEEWIZE@aol.com), Ultralink's CEO said, "We're pleased that a team
as qualified as that put together by ArcScan has agreed to drive the evolution of this critically
important diagnositc device, and the principals of Ultralink look forward to helping ArcScan
become a major force in the industry."

ArcScan was founded to further the development of the Artemis technology. It is based in
Morrison, Colorado, and has received its initial round of funding support from its founders.

Forward-Looking Statements This press release contains statements that are forward-looking in nature. Statements preceded by the words believe, expect, anticipate, plan, intend, continue, estimate, may, will and similar expressions are forward-looking statements. Forward-looking statements are based on the Corporation’s beliers and assumptions based on information available at the time the assumption was made. Forward-looking statements relate to, among other things, anticipated financial performance, business prospects, strategies, regulatory developments, new services, market forces, commitments and technological developments, relating to the Corporation. By its nature, such forward-looking information is subject to various risks and uncertainties which could cause the Corporation’s actual results and experience to differ materially from the anticipated results or other expectations expressed. Those risks and uncertainties include, but are not limited to ArcScan’s ability to raise additional capital, ArcScan’s ability to execute its business plan while maintaining at all times its various regulatory approvals, and the competitive response from existing and potential competitors. Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date it is expressed in this document, and the Corporation undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events, or otherwise.